双特异性抗体在皮肤病学中的使用/应用进展:一篇综述
Ting Zhang1, Yang Liu2, Pei Xiong Liew3
1Department of Dermatology, Tianjin Institute of Integrative Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Frontiers in allergy
|September 5, 2025
概括
双特异性抗体同时结合两种抗原,可增强治疗效果,减少皮肤疾病的副作用. 这篇评论探讨了它们在治疗炎症,瘤和传染性皮肤疾病方面的潜力.
科学领域:
- 生物医学
- 免疫学
- 皮肤病学
背景情况:
- 双特异性抗体是合成的蛋白质,可以同时结合两个不同的抗原.
- 与单克隆抗体不同,它们的双重向能力允许同时调节多个途径.
- 这种双重向机制提高了治疗效果,并最大限度地降低了非向毒性.
研究的目的:
- 审查双特异性抗体的基本概念.
- 探索双特异性抗体在治疗各种皮肤疾病中的潜在应用.
- 讨论皮肤病学两种特异性抗体的现状和未来前景.
主要方法:
- 对双特异性抗体技术的文献审查.
- 在临床前和临床皮肤学研究中对双特异性抗体应用的分析.
- 对炎症性,瘤性和传染性皮肤疾病的双特异性抗体的当前研究综合.
主要成果:
- 双特异性抗体在改善皮肤疾病治疗结果方面具有显著的潜力.
- 对瘤抗原进行向的治疗降低了全身毒性.
- 同时针对多种与疾病相关的抗原提供协同治疗效果.
结论:
- 双特异性抗体在皮肤治疗中是一个有前途的进步.
- 需要进一步的研究和临床试验才能充分发挥其治疗皮肤疾病的潜力.
- 这一审查为未来的皮肤学研究和两种特异性抗体的临床应用提供了基础.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Confocal Fluorescence Microscopy
14.1K
Confocal microscopy is an advanced microscopic technique. The prime advantage of the confocal microscope over other microscopy techniques is its ability to block the out-of-focus light from the illuminated samples using pinholes. It is widely used with fluorescence optics to obtain high-resolution, sharp contrast images. Unlike optical microscopes, confocal microscopes use a focused beam of light laser to scan the entire sample surface at different z-planes. These microscopes are, therefore,...
14.1K
Cross-reactivity
31.5K
Overview
31.5K


